Medication Management Through Collaborative Practice for Children With Medical Complexity: A Prospective Case Series
- PMID: 38596413
- PMCID: PMC11001202
- DOI: 10.5863/1551-6776-29.2.119
Medication Management Through Collaborative Practice for Children With Medical Complexity: A Prospective Case Series
Abstract
Objective: Care coordination for children and youth with special health care needs and medical complexity (CYSHCN-CMC), especially medication management, is difficult for providers, parents/caregivers, and -patients. This report describes the creation of a clinical pharmacotherapy practice in a pediatric long-term care facility (pLTCF), application of standard operating procedures to guide comprehensive medication management (CMM), and establishment of a collaborative practice agreement (CPA) to guide drug therapy.
Methods: In a prospective case series, 102 patients characterized as CYSHCN-CMC were included in this pLTCF quality improvement project during a 9-month period.
Results: Pharmacists identified, prevented, or resolved 1355 drug therapy problems (DTP) with an average of 13 interventions per patient. The patients averaged 9.5 complex chronic medical conditions with a -median length of stay of 2815 days (7.7 years). The most common medications discontinued due to pharmacist assessment and recommendation included diphenhydramine, albuterol, sodium phosphate enema, ipratropium, and metoclopramide. The average number of medications per patient was reduced from 23 to 20. A pharmacoeconomic analysis of 244 of the interventions revealed a monthly direct cost savings of $44,304 ($434 per patient per month) and monthly cost avoidance of $48,835 ($479 per patient per month). Twenty-eight ED visits/admissions and 61 clinic and urgent care visits were avoided. Hospital -readmissions were reduced by 44%. Pharmacist recommendations had a 98% acceptance rate.
Conclusions: Use of a CPA to conduct CMM in CYSHCN-CMC decreased medication burden, resolved, and prevented adverse events, reduced health care-related costs, reduced hospital readmissions and was well-accepted and implemented collaboratively with pLTCF providers.
Keywords: adverse drug reactions; children with disability; chronic disease; drug-related side effects; economics; long-term care; medication management; pharmaceutical; pharmacist.
Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: membership@pediatricpharmacy.org.
Conflict of interest statement
Disclosure. The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. Heather Monk Bodenstab is an employee of Sobi, a pharmaceutical company, but Sobi provided no support for this study or publication of this article. Jena Quinn, Heather Monk Bodenstab, and Emily Wo had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis.
Figures
Similar articles
-
Medication therapy management: 10 years of experience in a large integrated health care system.J Manag Care Pharm. 2010 Apr;16(3):185-95. doi: 10.18553/jmcp.2010.16.3.185. J Manag Care Pharm. 2010. PMID: 20331323 Free PMC article.
-
Economic and utilization outcomes of medication management at a large Medicaid plan with disease management pharmacists using a novel artificial intelligence platform from 2018 to 2019: a retrospective observational study using regression methods.J Manag Care Spec Pharm. 2021 Sep;27(9):1186-1196. doi: 10.18553/jmcp.2021.21036. Epub 2021 May 25. J Manag Care Spec Pharm. 2021. PMID: 34032130 Free PMC article.
-
Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):731-6. doi: 10.1331/JAPhA.2008.07070. J Am Pharm Assoc (2003). 2008. PMID: 19019801
-
Making the economic value proposition for pharmacist comprehensive medication management (CMM) in primary care: A conceptual framework.Res Social Adm Pharm. 2020 Oct;16(10):1416-1421. doi: 10.1016/j.sapharm.2020.01.001. Epub 2020 Jan 2. Res Social Adm Pharm. 2020. PMID: 31918964 Review.
-
Caregiver-Based Interventions to Optimize Medication Safety in Vulnerable Elderly Adults: A Systematic Evidence-Based Review.J Am Geriatr Soc. 2018 Nov;66(11):2128-2135. doi: 10.1111/jgs.15556. Epub 2018 Aug 23. J Am Geriatr Soc. 2018. PMID: 30136714 Free PMC article.
Cited by
-
Polypharmacy-An Important Contributor to Health and Safety for Children With Medical Complexity: How Can We Improve Care for This Vulnerable Population?J Pediatr Pharmacol Ther. 2024 Apr;29(2):96-99. doi: 10.5863/1551-6776-29.2.96. Epub 2024 Apr 8. J Pediatr Pharmacol Ther. 2024. PMID: 38596412 Free PMC article. No abstract available.
-
Clinical pharmacists' interventions about drug therapy problems and its acceptability by prescribers among pediatric hospitalized patients with infectious diseases in resource-limited settings.BMC Infect Dis. 2025 Apr 29;25(1):629. doi: 10.1186/s12879-025-11044-9. BMC Infect Dis. 2025. PMID: 40301792 Free PMC article.
References
-
- Cohen E, Berry JG, Sanders L, et al. Status complexicus? The emergence of pediatric complex care. Pediatrics. 2018;141(suppl 3):S202–S211. - PubMed
-
- Kuo DZ, Houtrow AJ, Council on Children With Disabilities Recognition and management of medical complexity. Pediatrics. 2016;138(6):e20163021. - PubMed
-
- Davies SC, Lundine JP, Justice AF. Care coordination for children with special health care needs: a scoping review to inform strategies for students with traumatic brain injuries. J Sch Health. 2022;92(3):270–281. - PubMed
LinkOut - more resources
Full Text Sources